Other

Derivatives

Edwards Lifesciences Derivatives increased by 144.8% to $14.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.6%, from $26.60M to $14.20M. Over 2 years (FY 2023 to FY 2025), Derivatives shows a downward trend with a -50.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2021
Last reportedQ2 2025

How to read this metric

An increase suggests the company is locking in favorable long-term pricing for its operational inputs.

Detailed definition

This represents the fair value of derivative financial instruments that are expected to be settled or realized beyond th...

Peer comparison

Reflects the duration of the company's hedging strategy compared to industry peers.

Metric ID: other_derivative_assets_noncurrent

Historical Data

10 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$23.40M$27.90M$30.50M$21.80M$34.70M$26.60M$3.10M$5.10M$5.80M$14.20M
QoQ Change—+19.2%+9.3%-28.5%+59.2%-23.3%-88.3%+64.5%+13.7%+144.8%
YoY Change————+48.3%-4.7%-89.8%-76.6%-83.3%-46.6%
Range$3.10M – $34.70M
CAGR-19.9%
Avg YoY Growth-42.1%
Median YoY Growth-61.6%
Current Streak3 quarters growth

Frequently Asked Questions

What is Edwards Lifesciences's derivatives?
Edwards Lifesciences (EW) reported derivatives of $14.20M in Q1 2026.
How has Edwards Lifesciences's derivatives changed year-over-year?
Edwards Lifesciences's derivatives decreased by 46.6% year-over-year, from $26.60M to $14.20M.
What is the long-term trend for Edwards Lifesciences's derivatives?
Over 2 years (2023 to 2025), Edwards Lifesciences's derivatives has grown at a -50.2% compound annual growth rate (CAGR), from $23.40M to $5.80M.
What does derivatives mean?
The value of derivative contracts expected to be settled after one year that are currently in the company's favor.